Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Operating Income

Profit from core operations after operating expenses, before interest and taxes.

Organigram Global Inc.NASDAQ: OGI

Operating Income · Q2 FY2026 · quarter ended Mar 2026

Operating income remains negative

Q2 FY2026 operating income was -CA$9.79M, compared with -CA$7.58M a year earlier. Trailing-twelve-month operating income was -CA$14.13M.

Context

  • Operating income amounted to 34.1% of revenue in FY2025, up 11.8 pp from a year earlier.
  • Operating income grew in size in 2 of the last 3 fiscal years.

What to watch

Whether operating income reaches the consensus estimate from 3 analysts of CA$76.52M (+220.7%) for the fiscal year ending Sep 2026, a step up from the -77.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$9.79M-186.5% QoQ
Last fiscal yearSep 2025
-CA$63.41M-77.7% YoY
LTMMar 2026
-CA$14.13M+26.2% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-29.1%+80.3%+109.4 pp
1 year-77.7%+220.7%+298.4 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

CAD · from the income statement

Latest · FY2025
(63.41M) CAD
Year-over-year change
-77.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +26.2% is the 3rd highest of 9, against a peer median of -10.9%.
  • Operating income amounts to 5.2% of revenue for OGI, versus a peer median of 18.5%.
OGI Competitors
Operating Income for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ELMDElectromed, Inc.LTM Mar 2026$13.31M USD+48.6%+49.2%18.5%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$12.89M USD+54.3%+93.2%9.1%
ACBAurora Cannabis Inc.LTM Mar 2026CA$789.11K CAD-84.1%—0.3%
LFCRLifecore Biomedical, Inc.LTM Mar 2026-$78K USD——0.1%
DERMJourney Medical CorporationLTM Mar 2026-$6.34M USD+8.3%—9.8%
OGIOrganigram Global Inc.LTM Mar 2026-CA$14.13M CAD+26.2%—5.2%
HSDTSolana CompanyLTM Mar 2026-$18.86M USD-30.1%—196.6%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026-$54.96M USD+20.1%—168.0%
RNACCartesian Therapeutics, Inc.LTM Mar 2026-$91.32M USD-74.1%—5144.5%
IVAInventiva S.A.FY2025-€130.95M EUR-34.2%—2921.0%
Peer median (excluding OGI) —-10.9%+71.2%18.5%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.